NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









EBAMed SA

EBAMed SA

Private
GenevaHealthcare & Life Scienceshttps://eba-med.com/

Last Round

Series A

Extension

Jan 27, 2025

Total Funding Raised

$41.06M

Company Overview

EBAMed SA is a medical devices company that develops innovative solutions for the non-invasive treatment of heart arrhythmias using external beam ablation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

proton therapycardiac radioablationmedical devicebeam synchronizationmotion trackingventricular tachycardianon-invasive surgerymedical imagingcardiac arrhythmiaAI medical deviceimage-guided therapyradiation oncologymedtechAI-driven surgerydigital health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EBAMed SA Comps

Public and private peers based on sector, stage, and business model.

EBAMed SA comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

EBAMed SA Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionJan 27, 2025
Series AJan 24, 2024
Series AJun 27, 2023
SeedSep 28, 2022
GrantSep 23, 2020
Seed
Aug 21, 2019

Key People

Founding team and executive leadership

Marina Izzo

Chief Executive Officer

Executive Team

Adriano Garonna

Chief Technology Officer

Executive Team

EBAMed SA Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 24, 2024

    $17.38M round closed

  • Oct 30, 2018

    $80K round from MassChallenge Switzerland

EBAMed SA Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EBAMed SA Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EBAMed SA's valuation, stock price, and market status.

Firmographic Details

HeadquartersGeneva
Employee Range17
Year Founded2018
Last FundingJan 27, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.